{"id":7294,"date":"2026-03-23T11:27:20","date_gmt":"2026-03-23T11:27:20","guid":{"rendered":"https:\/\/oncopeptides.com.haus.se\/newsroom\/news\/vd-sofia-heigis-presenterade-vid-redeye-evenanget-commercialization-in-life-science\/"},"modified":"2026-03-23T11:27:20","modified_gmt":"2026-03-23T11:27:20","slug":"vd-sofia-heigis-presenterade-vid-redeye-evenanget-commercialization-in-life-science","status":"publish","type":"news","link":"https:\/\/oncopeptides.com.haus.se\/sv\/nyheter\/vd-sofia-heigis-presenterade-vid-redeye-evenanget-commercialization-in-life-science\/","title":{"rendered":"VD Sofia Heigis presenterade vid Redeye-evenanget Commercialization in Life Science"},"content":{"rendered":"<p>Oncopeptides VD Sofia Heigis presenterade nyligen bolaget vid Redeye-evenemanget Commercialization in Life Science. Presentationen f\u00f6ljdes av en fr\u00e5gestund. <\/p>\n<p><a href=\"https:\/\/www.redeye.se\/video\/event-presentation\/1157844\/oncopeptides-ceo-sofia-heigis-presents-at-redeye-commercialization-in-life-science-theme-event-march-20-2026\" target=\"_blank\" rel=\"noopener noreferrer\">Se presentationen h\u00e4r<\/a> eller klicka p\u00e5 videon nedan (presentationen \u00e4r p\u00e5 svenska).<\/p>\n<p><iframe title=\"260320 Oncopeptides\" src=\"https:\/\/player.vimeo.com\/video\/1175511360?dnt=1&amp;app_id=122963\" width=\"800\" height=\"450\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture; clipboard-write; encrypted-media; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\"><\/iframe><\/p>\n","protected":false},"featured_media":7293,"template":"","meta":{"_acf_changed":false},"news_categories":[365],"protected-content":[],"class_list":["post-7294","news","type-news","status-publish","has-post-thumbnail","hentry","news_categories-investerare"],"acf":[],"_links":{"self":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news\/7294","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/media\/7293"}],"wp:attachment":[{"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/media?parent=7294"}],"wp:term":[{"taxonomy":"news_categories","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/news_categories?post=7294"},{"taxonomy":"protected-content","embeddable":true,"href":"https:\/\/oncopeptides.com.haus.se\/sv\/wp-json\/wp\/v2\/protected-content?post=7294"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}